Acceleration and Augmentation of Antidepressants With Lithium for Depressive Disorders: Two Meta-Analyses of Randomized, Placebo-Controlled Trials
The DOI matches its Crossref record.
Abstract
OBJECTIVE: The delayed onset of therapeutic response and the high number of nonresponders to antidepressants remain major clinical problems in depressive disorders. Among the strategies to overcome both dilemmas, the additional treatment with lithium has been suggested as a viable method. The authors determined in 2 separate meta-analyses the efficacy of lithium in accelerating and in augmenting clinical response in patients with depression. STUDY SELECTION AND DATA SOURCES: Two meta-analyses of randomized, double-blind, placebo-controlled trials including subjects with unipolar or bipolar disorder, depressive phase, assessed the concomitant administration of lithium and antidepressant to accelerate or augment clinical response in the acute treatment phase of depression. Data were obtained from searching the following databases: MEDLINE (1966 to July 2006), EMBASE (1989 to July 2006), and The Cochrane Central Register of Controlled Trials (The Cochrane Library 2006, Issue 3). For the accelerating meta-analysis, subject headings including depressive disorder, bipolar disorder, antidepressive agents, and lithium and text words such as depress*, lithium, and antidepress* were used. For the augmentation meta-analysis, subject headings included depressive disorder, bipolar disorder, anti-depressive agents, lithium, drug therapy, and combination, and text words included augment*, refract*, and resistant. Outcomes investigated included response rates and depression scale rates. DATA SYNTHESIS: Five acceleration studies (231 participants) adding lithium to tricyclics and tetracyclics and 10 augmentation studies (269 participants) adding lithium to various antidepressants including selective serotonin reuptake inhibitors were incorporated. In the acceleration meta-analysis, a statistical trend in favor of lithium was found (standardized mean difference of -0.43, 95% CI = -0.93 to 0.07). In the augmentation meta-analysis, lithium was significantly more effective than placebo (odds ratio = 3.11, 95% CI = 1.80 to 5.37). CONCLUSION: There is firm evidence for lithium as an effective augmentation strategy but only modest evidence for lithium to accelerate response to antidepressants in patients with depressive disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The extant evidence supporting lithium and thyroid hormone largely refers to their combination with TCAs and MAOIs in patients with partial response to these agents.”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [277]
Citations
Cites
Still being checked.
Cited by
Items 101–200 of 244
Sarai, S. K., Mekala, H. M., & Lippmann, S. (2018) · Europe PMC (PubMed Central) · Cited by 38
Effects of somatic treatments on suicidal ideation and completed suicides
Hawkins, E. M., Coryell, W. H., Leung, S., Parikh, S. V., Weston, C. L., Nestadt, P. S., Nürnberger, J. I., Kaplin, A. I., Kumar, A., Farooqui, A. A., et al. (2021) · Brain and Behavior · doi:10.1002/brb3.2381 · Cited by 31
Lithium treatment in the era of personalized medicine
RYBAKOWSKI, J. K. (2020) · Drug Development Research · doi:10.1002/ddr.21660 · Cited by 29
the EMC Study Group, Tadić, A., Gorbulev, S., Dahmen, N., Hiemke, C., Braus, D. F., Röschke, J., van Calker, D., Wachtlin, D., Kronfeld, K., et al. (2010) · Trials · doi:10.1186/1745-6215-11-21 · Cited by 29
Lithium levels in tap water and psychotic experiences in a general population of adolescents
Shimodera, S., Koike, S., Ando, S., Yamasaki, S., Fujito, R., Endo, K., Iijima, Y., Yamamoto, Y., Morita, M., Sawada, K., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.05.019 · Cited by 30
Giakoumatos, C. I., & Osser, D. (2019) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000197 · Cited by 27
Baghai, T. C., Blier, P., Baldwin, D. S., Bauer, M., Goodwin, G. M., Fountoulakis, K. N., Kasper, S. F., Leonard, B. E., Malt, U. F., Stein, D. J., et al. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0274-7 · Cited by 31
Self-citationMaust, D. T., Oslin, D. W., & Thase, M. E. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.030 · Cited by 25
Chang, C., Sato, S., & Han, C. (2013) · CNS Drugs · doi:10.1007/s40263-012-0030-1 · Cited by 26
Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol
Furukawa, T. A., Akechi, T., Shimodera, S., Yamada, M., Miki, K., Watanabe, N., Inagaki, M., & Yonemoto, N. (2011) · Trials · doi:10.1186/1745-6215-12-116 · Cited by 23
“The ones with most randomized evidence include lithium augmentation [22], thyroid hormone augmentation [23] and augmentation with atypical antipsychotics [24].”
BackgroundBschor, T., Ritter, D., Winkelmann, P., Erbe, S., Uhr, M., Ising, M., & Lewitzka, U. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027613 · Cited by 23
“, lithium in the form of lithium augmentation is a major strategy for treating (unipolar) depression not responding to antidepressant monotherapy”
BackgroundYoshimura, R., Kishi, T., Hori, H., Ikenouchi, A., Katsuki, A., Umene‐Nakano, W., Iwata, N., & Nakamura, J. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.008 · Cited by 26
Köhler, S., Unger, T., Hoffmann, S., Steinacher, B., Fydrich, T., & Bschor, T. (2012) · Pharmacopsychiatry · doi:10.1055/s-0032-1323677 · Cited by 27
Shim, I. H., Woo, Y. S., Kim, M.-D., & Bahk, W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112406 · Cited by 26
Recent Findings and Current Status of Augmentation Strategies
Nelson, J. C. (2007) · CNS Spectrums · doi:10.1017/s1092852900016011 · Cited by 23
Nelson, J. C., & Papakostas, G. I. (2010) · Focus · doi:10.1176/foc.8.4.foc570 · Cited by 23
Algorithm‐guided treatment versus treatment as usual for major depression
Yoshino, A., Sawamura, T., Kobayashi, N., Kurauchi, S., Matsumoto, A., & Nomura, S. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02009.x · Cited by 22
Maust, D. T., Oslin, D. W., & Thase, M. E. (2012) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31826576cf · Cited by 22
Dold, M., Bartova, L., Kautzky, A., Serretti, A., Porcelli, S., Souery, D., Mendlewicz, J., Montgomery, S., Zohar, J., & Kasper, S. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.10.003 · Cited by 21
Kvetny, J., Ellervik, C., & Bech, P. (2014) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2014.972454 · Cited by 20
Transferable interactions of Li+ and Mg2+ ions in polarizable models
Wineman‐Fisher, V., Delgado, J. M., Nagy, P. R., Jakobsson, E., Pandit, S. A., & Varma, S. (2020) · The Journal of Chemical Physics · doi:10.1063/5.0022060 · Cited by 20
Targeting Treatment-Resistant Depression
Mathys, M. L., & Mitchell, B. G. (2011) · Journal of Pharmacy Practice · doi:10.1177/0897190011426972 · Cited by 22
Optimized Treatment Strategy for Depressive Disorder
Chen, P. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9271-0_11 · Cited by 23
Delcourte, S., Etiévant, A., & Haddjeri, N. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.002 · Cited by 18
Therapeutic Armamentarium for Treating Depression
Howland, R. H. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.07.2176 · Cited by 15
Pringsheim, T. M., Gardner, D. M., & Patten, S. B. (2015) · BMJ · doi:10.1136/bmj.h569 · Cited by 15
Birkenhäger, T. K., van den Broek, W. W., Wijkstra, J., Bruijn, J. A., van Os, E., Boks, M. P., Verkes, R. J., Janzing, J., & Nolen, W. A. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181b6744e · Cited by 13
(1982) · NASSP Bulletin · doi:10.1177/019263658206645308 · Cited by 13
Li, H., Yu, X. L., Yang, K., He, C.-Y., Kou, S., Cao, S., & Xie, G. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0232 · Cited by 12
Thase, M. E. (2009) · CNS Spectrums · doi:10.1017/s1092852900003515 · Cited by 12
Pharmacological treatment approaches to difficult‐to‐treat depression
Chan, H., Mitchell, P. B., Loo, C. K. A., & Harvey, S. B. (2013) · The Medical Journal of Australia · doi:10.5694/mja12.10495 · Cited by 14
Polygenic Contributions to Lithium Augmentation Outcomes in Unipolar Depression
Kraft, J., Buspavanich, P., Braun, A., Panagiotaropoulou, G., Schlattmann, P., Buchbauer, H., Heilbron, K., Heilbronner, U., Schulze, T. G., Ripke, S., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.2039 · Cited by 9
Lithium and bipolar depression
Manchia, M., RYBAKOWSKI, J. K., Sani, G., Kessing, L. V., Murru, A., Alda, M., & Tondo, L. (2019) · Bipolar Disorders · doi:10.1111/bdi.12781 · Cited by 10
Yoshimura, R., Kishi, T., Hori, H., Ikenouchi, A., Umene‐Nakano, W., Katsuki, A., Hayashi, K., Iwata, N., & Nakamura, J. (2012) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2012.10.1.49 · Cited by 10
Psychopharmaka zur Behandlung suizidaler Patienten und zur Suizidprävention
Haußmann, R., Bauer, M., Lewitzka, U., & Müller-Oerlinghausen, B. (2016) · Der Nervenarzt · doi:10.1007/s00115-016-0088-y · Cited by 10
Self-citationCorral, R. M., Giraldo, E. B., Cetkovich, M., Córdoba, R., Chestaro, J., Gama, C. S., Bonetto, G. G., López‐Jaramillo, C., Moreno, R. A., Ng, B., et al. (2023) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.sjpmh.2023.06.001 · Cited by 11
Age as a Determinant of Instability of Serum Lithium Concentrations
van Melick, E. J. M., Souverein, P. C., den Breeijen, J. H., Tusveld, C. E., Egberts, T. C. G., & Wilting, I. (2013) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31828f017d · Cited by 9
van Melick, E. J. M., Wilting, I., Souverein, P. C., & Egberts, T. C. G. (2012) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2012.02.001 · Cited by 8
Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression
Gartlehner, G., Hansen, R. A., Morgan, L. C., Thaler, K. J., Lux, L. J., Noord, M. V., Mager, U., Gaynes, B. N., Thieda, P., Strobelberger, M., et al. (2011) · Cited by 8
Haji, E. O., Wagner, S., Fric, M., Laux, G., Pittermann, P., Roschke, J., & Hiemke, C. (2013) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31828d221f · Cited by 8
Shtein, L., Toker, L., Bersudsky, Y., Belmaker, R., & Agam, G. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2969-0 · Cited by 8
Hemodialysis Treatment for Patients with Lithium Poisoning
Liu, Y.-H., Tsai, K., Hsu, P.-C., Hsieh, M.-H., Fu, J., Wang, I., Liu, S.-H., Weng, C., Huang, W., Hsu, C., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610044 · Cited by 8
Dépression résistante : les stratégies de potentialisation
Doumy, O., Bennabi, D., El‐Hage, W., Allaïli, N., Bation, R., Bellivier, F., Holtzmann, J., Bubrovszky, M., Camus, V., Charpeaud, T., et al. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.02.004 · Cited by 11
Barbisan, F., Azzolin, V. F., Monteiro, G. C., Teixeira, C. F., Mastella, M. H., Bueno, V., Duarte, M. M. M. F., Wagner, G., do Prado‐Lima, P. A. S., Ribeiro, E. E., et al. (2018) · Gene · doi:10.1016/j.gene.2018.02.046 · Cited by 9
Definition and Epidemiology of Treatment Resistance in Psychiatry
Smith-Apeldoorn, S. Y., Veraart, J. K. E., & Schoevers, R. A. (2018) · Springer eBooks · doi:10.1007/978-981-10-4358-1_1 · Cited by 11
Long-Term Outcome after Lithium Augmentation in Unipolar Depression: Focus on HPA System Activity
Adli, M., Bschor, T., Bauer, M., Lucka, C., Lewitzka, U., Ising, M., Uhr, M., Müller-Oerlinghausen, B., & Baethge, C. (2009) · Neuropsychobiology · doi:10.1159/000234814 · Cited by 8
Self-citationVermeiden, M., Kamperman, A. M., Hoogendijk, W. J. G., van den Broek, W. W., & Birkenhäger, T. K. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12743 · Cited by 7
Lithium, Thyroid Hormones and Further Augmentation Strategies in Treatment‐resistant Depression
Haußmann, R., & Bauer, M. (2013) · Wiley eBooks · doi:10.1002/9781118556719.ch6 · Cited by 7
Self-citationLithium: Underappreciated and Underused?
Howland, R. H. (2007) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20070801-04 · Cited by 10
Sakamoto, K., Sugawara, H., Harada, T., Shimizu, S., & Ishigooka, J. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s104115 · Cited by 7
Paton, C., Anderson, I. M., Cowen, P. J., Delgado, O., & Barnes, T. R. E. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320930492 · Cited by 8
Treatment resistant depression
Vaccarino, S. R., & Kennedy, S. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821033-8.00003-4 · Cited by 8
Current Status of Lithium in the Treatment of Mood Disorders
Malhi, G. S., McAulay, C., & Fritz, K. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-014-0018-1 · Cited by 7
Add-on lithium for the treatment of unipolar depression: Too often forgotten?
Jollant, F. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140162 · Cited by 7
The use of sequential pharmacotherapy for the treatment of acute major depression: a scoping review
Jones, B. D. M., Husain, M. I., & Mulsant, B. H. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1878144 · Cited by 7
Zhu, Y., Kim, M. H., Banerjee, S., Deferio, J. J., Alexopoulos, G. S., & Pathak, J. (2018) · JAMIA Open · doi:10.1093/jamiaopen/ooy001 · Cited by 6
Polypharmazie in der Behandlung depressiver Störungen
Schmauß, M., & Messer, T. (2009) · Springer eBooks · doi:10.1007/978-3-211-79826-3_1 · Cited by 5
Baldessarini, R. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3710-9_3 · Cited by 9
Managing Depression in Clinical Practice
Friedman, E. S., & Anderson, I. M. (2010) · Springer eBooks · doi:10.1007/978-1-84996-465-4 · Cited by 5
Outcome of a three‐phase treatment algorithm for inpatients with melancholic depression
Vermeiden, M., Kamperman, A., Hoogendijk, W., van den Broek, W. W., & Birkenhäger, T. (2018) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.03.002 · Cited by 5
Chronische Depression: Klassifikation und Behandlungsstrategien
Mikoteit, T., & Hatzinger, M. (2009) · Zeitschrift für Psychiatrie Psychologie und Psychotherapie · doi:10.1024/1661-4747.57.4.245 · Cited by 6
Lavretsky, H., & Roose, S. P. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.10.009 · Cited by 4
Kolshus, E., Douglas, L., & Dunne, R. A. (2011) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700011800 · Cited by 3
ATP-Ion Complexation and Lithium’s Bioactive Form in Cellular Solutions
Delgado, J. M., Klein, P. S., & Varma, S. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c04061 · Cited by 4
Pharmakologische Behandlungsmöglichkeiten bei therapieresistenter Depression
Kahl, K. G. (2012) · Nervenheilkunde · doi:10.1055/s-0038-1628182 · Cited by 4
Evidence-based pharmacotherapy of major depressive disorder
Dupuy, J. M., Ostacher, M. J., Huffman, J. C., Perlis, R. H., & Nierenberg, A. A. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511910395.005 · Cited by 4
Bhavya, Shetty, S., & Sadasivam, B. (2025) · Cureus · doi:10.7759/cureus.91829 · Cited by 3
Kronsell, A., Nordenskjöld, A., Bodén, R., Mittendorfer‐Rutz, E., Reutfors, J., Rossides, M., & Tiger, M. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03746-0 · Cited by 2
Une approche clinico-phénoménologique des dépressions résistantes
Ledoux, A., Cioltea, D., & Angeletti, L. (2013) · L Encéphale · doi:10.1016/j.encep.2013.03.011 · Cited by 4
RYBAKOWSKI, J. K. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_45-1 · Cited by 2
Birkenhäger, T. K., Shapiro-Koss, C., & Kamperman, A. M. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001359 · Cited by 2
Pharmacological treatment of treatment-resistant depression: Towards evidence-based recommendations
Jerotić, S., & Ivković, M. (2024) · Medicinska istrazivanja · doi:10.5937/medi57-48086 · Cited by 2
Han, K., Park, S., Won, E., Sung, S.-H., Lee, H., Koo, J.-W., Lee, K., Lee, H.-Y., Paik, J., Jeon, H. J., et al. (2013) · 신경정신의학 · doi:10.4306/jknpa.2013.52.5.386 · Cited by 2
Commentary on STAR*D: a summary and UK perspective
Cowen, P. J. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109104887 · Cited by 2
Eckert, D., & Kasper, S. F. (2026) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2026.2617195 · Cited by 3
Stratégie thérapeutique des épisodes dépressifs. Prévention du risque de récidive
Nuss, P. (2010) · L Encéphale · doi:10.1016/s0013-7006(10)70048-8 · Cited by 1
Ochs, B., & Bschor, T. (2016) · Springer eBooks · doi:10.1007/978-3-662-50347-8_12 · Cited by 2
Medikamente zur Behandlung bipolarer affektiver Störungen
Grunze, H., & Bauer, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_54 · Cited by 4
Self-citationTedaviye Dirençli Depresyonlarda Yeni Antipsikotiklerin Yeri
Çetin, M. (2010) · Cited by 3
Kato, H., Koizumi, T., Takeuchi, H., Tani, H., Mimura, M., & Uchida, H. (2020) · Pharmacopsychiatry · doi:10.1055/a-1330-8587 · Cited by 1
Lewitzka, U., & Haußmann, R. (2022) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-021-2201-4 · Cited by 2
Lithium in Psychiatric Indications
Schefft, C., Volkmann, C., & Köhler, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_447 · Cited by 1
RYBAKOWSKI, J. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_45 · Cited by 1
Therapiemöglichkeiten der Depression nach Non-Response: Ein Update für die Praxis
Walter, H., Haaf, R., & Köhler, S. (2023) · Nervenheilkunde · doi:10.1055/a-2103-7920 · Cited by 1
Chugh, P., & Mahapatro, F. (2024) · Annals of Indian Psychiatry · doi:10.4103/aip.aip_107_24 · Cited by 1
Antidepressant-Antianxiety Agents
Baldessarini, R. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3710-9_4 · Cited by 1
Chronische und therapieresistente Depression (ICD-10 F3)
Schramm, E., & BAUER, M. (2008) · Elsevier eBooks · doi:10.1016/b978-343724780-4.50012-9 · Cited by 1
Self-citationReply to Comments by Drs Carroll and Tsai Regarding Marcus et al
Berman, R. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318193cc05 · Cited by 2
Tamayo, J. M., Rosales-Barrera, J. I., Villaseñor-Bayardo, S. J., & Rojas-Malpica, C. (2011) · Salud Mental · Cited by 5
Factors predicting inefficacy of lithium in patients with Bipolar I Disorder
Herweijer, D. M. C. (2015) · Utrecht University Repository (Utrecht University)
Chronische und therapieresistente Depressionen (ICD-10 F3)
Schramm, E., & Bauer, M. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50012-5
Self-citationMedikamente zur Behandlung bipolarer affektiver Störungen
Grunze, H., & Forsthoff, A. (2008) · Springer eBooks · doi:10.1007/978-3-540-68748-1_29
La depressione maggiore resistente: update delle strategie di trattamento farmacologico
Bellantuono, C. (2011) · Quaderni Italiani di Psichiatria · doi:10.1016/j.quip.2011.08.001
Management of treatment nonresponse
Anderson, I. M. (2010) · Springer eBooks · doi:10.1007/978-1-84996-465-4_7
Drs. Nelson and Papakostas Reply
Nelson, J. C., & Papakostas, G. I. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09091257r
Lithium in older patients: treatment patterns and somatic adverse effects
van Melick, E. J. M. (2014) · Utrecht University Repository (Utrecht University)
No evidence for switching antidepressants in treatment-resistant depressed patients
Thase, M. E. (2010) · BMJ Evidence-Based Medicine · doi:10.1136/ebm1083
Lo, V., & Maggio, L. A. (2010) · PubMed
Metadata
- Authors
- Crossley, N. A., & Bauer, M.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-06-15
- Volume
- 68
- Issue
- 06
- Pages
- 935-940
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2010317561
- Cited by
- 246
- References
- 0
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 9 · 2023: 4 · 2022: 11 · 2021: 5 · 2020: 13 · 2019: 11 · 2018: 12 · 2017: 12 · 2016: 9 · 2015: 9 · 2014: 19 · 2013: 20 · 2012: 16
- FWCI
- 14.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- lithium, antidepressant augmentation, depression, bipolar disorder, treatment-resistant depression, tricyclic antidepressants, selective serotonin reuptake inhibitors, tetracyclic antidepressants, response rate
- MeSH terms
- Antidepressive Agents, Depressive Disorder, Drug Interactions, Drug Therapy, Combination, Humans, Randomized Controlled Trials as Topic, Lithium Carbonate, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.